EUVIMEDEUVIMED entdecken
Crossref

Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia

Phillip C Nguyen iD, Vuong Nguyen, Kylie Baldwin, Yamuna Kankanige, Piers Blombery iD, Neil Came, David A Westerman

British Journal of Haematology · 2023

DOI: 10.1111/bjh.18802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Phillip C Nguyen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Undetectable measurable residual disease (MRD) is associated with favourable clinical outcomes in chronic lymphocytic leukaemia (CLL). While assessment is commonly performed using multiparameter flow cytometry (MFC), this approach is associated with limitations including user bias and expertise that may not be widely available. Implementation of unsupervised clustering algorithms in the laboratory can address these limitations and have not been previously reported in a systematic quantitative manner. We developed a computational pipeline to assess CLL MRD using FlowSOM. In the training step, a self‐organising map was generated with nodes representing the full breadth of normal immature and mature B cells along with disease immunophenotypes. This map was used to detect MRD in multiple validation cohorts containing a total of 456 samples. This included an evaluation of atypical CLL cases and samples collected from two different laboratories. Computational MRD showed high correlation with expert analysis (Pearson's r > 0.99 for typical CLL). Binary classification of typical CLL samples as either MRD positive or negative demonstrated high concordance (>98%). Interestingly, computational MRD detected disease in a small number of atypical CLL cases in which MRD was not detected by expert analysis. These results demonstrate the feasibility and value of automated MFC analysis in a diagnostic laboratory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Lymphocytic, Chronic, B-CellNeoplasm, ResidualFlow CytometryImmunophenotypingHumansMachine Learning

Stichwörter der Autor:innen

chronic lymphocytic leukaemiaflow cytometrymachine learningmeasurable residual disease

Autor:innen und Institutionen

  • Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.

ORCID-Profile: Phillip C Nguyen, Piers Blombery

Zitieren

APA

Nguyen, P. C., Nguyen, V., Baldwin, K., Kankanige, Y., Blombery, P., Came, N., & Westerman, D. A. (2023). Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.18802

Vancouver

Nguyen PC, Nguyen V, Baldwin K, Kankanige Y, Blombery P, Came N, et al. Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia. British Journal of Haematology. 2023. doi:10.1111/bjh.18802

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Phillip C and Nguyen, Vuong and Baldwin, Kylie and Kankanige, Yamuna and Blombery, Piers and Came, Neil and Westerman, David A},
  title = {Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.18802}
}
Kostenlos starten →